The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics

E Pajarillo, A Rizor, J Lee, M Aschner, E Lee - Neuropharmacology, 2019 - Elsevier
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS)
which initiates rapid signal transmission in the synapse before its re-uptake into the …

The NRF2-dependent transcriptional regulation of antioxidant defense pathways: Relevance for cell type-specific vulnerability to neurodegeneration and therapeutic …

SM Boas, KL Joyce, RM Cowell - Antioxidants, 2021 - mdpi.com
Oxidative stress has been implicated in the etiology and pathobiology of various
neurodegenerative diseases. At baseline, the cells of the nervous system have the capability …

Rising stars: astrocytes as a therapeutic target for ALS disease

M Izrael, SG Slutsky, M Revel - Frontiers in neuroscience, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a multifactorial disease, characterized by a
progressive loss of motor neurons that eventually leads to paralysis and death. The current …

Glial cells—The strategic targets in amyotrophic lateral sclerosis treatment

T Filipi, Z Hermanova, J Tureckova, O Vanatko… - Journal of clinical …, 2020 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease, which is characterized by
the degeneration of motor neurons in the motor cortex and the spinal cord and subsequently …

Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases

L Zhang, Y Liu, Y Lu, G Wang - Biochemical pharmacology, 2022 - Elsevier
Nowadays, epigenetics is of great research value as a new gateway that can solve the
sophisticated mysteries behind neurodegenerative diseases. Epigenetic mechanisms …

Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis

W Zhou, R Xu - Frontiers in Neuroscience, 2023 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease
that leads to the massive loss of motor neurons in cerebrum, brain stem and spinal cord. It …

Mitochondrial dysfunction, neurogenesis, and epigenetics: putative implications for amyotrophic lateral sclerosis neurodegeneration and treatment

ML Calió, E Henriques, A Siena… - Frontiers in …, 2020 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a progressive and devastating multifactorial
neurodegenerative disorder. Although the pathogenesis of ALS is still not completely …

Epigenetic changes in prion and prion-like neurodegenerative diseases: Recent advances, potential as biomarkers, and future perspectives

A Hernaiz, JM Toivonen, R Bolea… - International journal of …, 2022 - mdpi.com
Prion diseases are transmissible spongiform encephalopathies (TSEs) caused by a
conformational conversion of the native cellular prion protein (PrPC) to an abnormal …

Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis

E Parrella, V Porrini, I Scambi, MM Gennari… - Frontiers in …, 2022 - frontiersin.org
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with
motor neuron degeneration, progressive paralysis and finally death. Despite the research …

Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis

YE Klingl, D Pakravan… - British Journal of …, 2021 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. ALS
patients suffer from a progressive loss of motor neurons, leading to respiratory failure within …